HK1045942A1 - 結合(s)-2-(苄胺甲基)-2，3，8，9，-四氫-7h-1，4-二氧(2，3)吲-8-酮及精神抑制藥 - Google Patents

結合(s)-2-(苄胺甲基)-2，3，8，9，-四氫-7h-1，4-二氧(2，3)吲-8-酮及精神抑制藥

Info

Publication number
HK1045942A1
HK1045942A1 HK02107378.5A HK02107378A HK1045942A1 HK 1045942 A1 HK1045942 A1 HK 1045942A1 HK 02107378 A HK02107378 A HK 02107378A HK 1045942 A1 HK1045942 A1 HK 1045942A1
Authority
HK
Hong Kong
Prior art keywords
dioxino
neuroleptics
benzylamino
indol
tetrahydro
Prior art date
Application number
HK02107378.5A
Other languages
English (en)
Inventor
Lovell Marquis Karen
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of HK1045942A1 publication Critical patent/HK1045942A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK02107378.5A 1999-12-10 2002-10-09 結合(s)-2-(苄胺甲基)-2，3，8，9，-四氫-7h-1，4-二氧(2，3)吲-8-酮及精神抑制藥 HK1045942A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45860799A 1999-12-10 1999-12-10
PCT/US2000/033060 WO2001041750A2 (en) 1999-12-10 2000-12-07 Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics

Publications (1)

Publication Number Publication Date
HK1045942A1 true HK1045942A1 (zh) 2002-12-20

Family

ID=23821437

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02107378.5A HK1045942A1 (zh) 1999-12-10 2002-10-09 結合(s)-2-(苄胺甲基)-2，3，8，9，-四氫-7h-1，4-二氧(2，3)吲-8-酮及精神抑制藥

Country Status (20)

Country Link
EP (1) EP1235570A2 (zh)
JP (1) JP5557409B2 (zh)
KR (1) KR100772854B1 (zh)
CN (1) CN1230164C (zh)
AR (1) AR026756A1 (zh)
AU (1) AU784211B2 (zh)
BR (1) BR0016168A (zh)
CA (1) CA2396351C (zh)
CZ (1) CZ20021880A3 (zh)
EA (1) EA005002B1 (zh)
HK (1) HK1045942A1 (zh)
HU (1) HUP0203309A3 (zh)
IL (2) IL149669A0 (zh)
MX (1) MXPA02005649A (zh)
NO (1) NO20022739D0 (zh)
NZ (1) NZ519381A (zh)
PL (1) PL355292A1 (zh)
TW (1) TWI222864B (zh)
WO (1) WO2001041750A2 (zh)
ZA (1) ZA200205484B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101409724B1 (ko) 2003-10-29 2014-06-19 와이어쓰 엘엘씨 아플린도어 및 이의 유도체를 포함하는 서방성 약제학적조성물
JP2008530229A (ja) 2005-02-17 2008-08-07 ワイス シクロアルキル縮合インドール、ベンゾチオフェン、ベンゾフランおよびインデン誘導体
ES2430622T3 (es) * 2008-02-13 2013-11-21 Targacept, Inc. Combinación de agonistas nicotínicos alfa 7 y antipsicóticos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2987484B2 (ja) * 1995-03-16 1999-12-06 大塚製薬 株式会社 カルボスチリル誘導体の製造方法
US5756532A (en) * 1995-11-06 1998-05-26 American Home Products Corporation Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives
GB9627005D0 (en) * 1996-12-27 1997-02-12 Knoll Ag Therapeutic agents

Also Published As

Publication number Publication date
AU1949001A (en) 2001-06-18
PL355292A1 (en) 2004-04-05
MXPA02005649A (es) 2004-09-10
WO2001041750A3 (en) 2002-02-14
KR100772854B1 (ko) 2007-11-02
IL149669A0 (en) 2002-11-10
IL149669A (en) 2006-06-11
ZA200205484B (en) 2003-12-31
CN1230164C (zh) 2005-12-07
JP5557409B2 (ja) 2014-07-23
EA200200656A1 (ru) 2002-12-26
CZ20021880A3 (cs) 2002-08-14
BR0016168A (pt) 2002-08-20
EP1235570A2 (en) 2002-09-04
WO2001041750A2 (en) 2001-06-14
AR026756A1 (es) 2003-02-26
KR20030016207A (ko) 2003-02-26
JP2003516350A (ja) 2003-05-13
NO20022739L (no) 2002-06-07
CA2396351A1 (en) 2001-06-14
HUP0203309A3 (en) 2004-12-28
NZ519381A (en) 2004-04-30
NO20022739D0 (no) 2002-06-07
CA2396351C (en) 2009-11-10
TWI222864B (en) 2004-11-01
HUP0203309A2 (hu) 2003-01-28
EA005002B1 (ru) 2004-10-28
AU784211B2 (en) 2006-02-23
CN1409633A (zh) 2003-04-09

Similar Documents

Publication Publication Date Title
AU2485100A (en) Left and right side heart support
AU2001280070A1 (en) Electrostimulation system with electromyographic and visual biofeedback
IL139286A0 (en) Polyol-ifn-beta conjugates, their preparation and use
HUP9903691A3 (en) Pesticidal karbanilide derivatives, preparation and use thereof
SI1019358T2 (sl) 3,3-diarilpropilamini, njihova uporaba in priprava
PL351250A1 (en) Antipicornaviral compounds, their preparation and use
ZA986421B (en) 2-[Pyrazolyl-and triazolyl-3'-oxymethylene]phenylisoxa zolones, -triazolones and - tetrazolones, their preparation and their use.
NZ330360A (en) 5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
AU3472799A (en) Dermatological formulations and methods
HUP0003811A3 (en) Oxyranyle-triazoline thiones, their preparation and their use as microbicides
AU2619797A (en) Silyl-linked polyamidoamines and their preparation
EP0673999A3 (en) Trehalose phosphorylase and its production.
AU6351199A (en) Pectins and the preparation thereof
ZA9810625B (en) Benzylidenepyrazolones, their preparation and use.
IL143082A0 (en) Benzofuran derivatives, their preparation and use
AU5446900A (en) Novel murine and human kinases
HK1045942A1 (zh) 結合(s)-2-(苄胺甲基)-2，3，8，9，-四氫-7h-1，4-二氧(2，3)吲-8-酮及精神抑制藥
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU4629399A (en) Substituted piperazones and their therapeutic uses
GB2332671B (en) Acetals, their preparation and their use
HUP0102988A3 (en) Peroxides, their preparation process and use
ZA982950B (en) Stabilized human papillomavirus formulations
AU2227999A (en) Human ependymin
GB9807586D0 (en) Enzymes and their use
AU5623599A (en) Aza-cyclodepsipeptides and their use as antiparasitics